Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Tamura

Showing results (751-760 of 770) with videos related to

Pageof 77
Sort By:
Genes to Cells : Devoted to Molecular & Cellular Mechanisms|January 29, 2000
Mouse Ror2 receptor tyrosine kinase is required for the heart development and limb formationS Takeuchi, K Takeda, I Oishi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 2016
Multicenter randomized phase II study of cisplatin and fluorouracil plus docetaxel (DCF) compared with cisplatin and fluorouracil plus Adriamycin (ACF) as preoperative chemotherapy for resectable esophageal squamous cell carcinoma (OGSG1003)M Yamasaki, T Yasuda, M Yano, et al.
Annals of Internal Medicine|July 21, 1998
Relation of interferon therapy and hepatocellular carcinoma in patients with chronic hepatitis C. Osaka Hepatocellular Carcinoma Prevention Study GroupY Imai, S Kawata, S Tamura, et al.
Liver|August 26, 2000
Long-term responders without eradication of hepatitis C virus after interferon therapy: characterization of clinical profiles and incidence of hepatocellular carcinomaI Yabuuchi, Y Imai, S Kawata, et al.
International Journal of Cancer|April 10, 1997
CYP1A1, CYP2E1 and GSTM1 polymorphisms are not associated with susceptibility to squamous-cell carcinoma of the esophagusS Morita, M Yano, H Shiozaki, et al.
Journal of Viral Hepatitis|March 5, 2004
Interferon treatment improves survival in chronic hepatitis C patients showing biochemical as well as virological responses by preventing liver-related deathA Kasahara, H Tanaka, T Okanoue, et al.
Biochemistry|August 17, 2005
Allosteric activation of protein phosphatase 2C by D-chiro-inositol-galactosamine, a putative mediator mimetic of insulin actionD L Brautigan, M Brown, S Grindrod, et al.
Diabetes|May 26, 2001
Pancreatic biopsy as a procedure for detecting in situ autoimmune phenomena in type 1 diabetes: close correlation between serological markers and histological evidence of cellular autoimmunityA Imagawa, T Hanafusa, S Tamura, et al.
Diabetologia|May 20, 1999
Immunological abnormalities in islets at diagnosis paralleled further deterioration of glycaemic control in patients with recent-onset Type I (insulin-dependent) diabetes mellitusA Imagawa, T Hanafusa, N Itoh, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 1, 1996
[Hepatic resection with "wrapping therapy" for advanced hepatocellular carcinoma uncontrolled by arterial embolization]Y Sasaki, S Imaoka, H Nakano, et al.
Pageof 77

Showing results (751-760 of 770) with videos related to

Sort By:
Pageof 77
Genes to Cells : Devoted to Molecular & Cellular Mechanisms|January 29, 2000
Mouse Ror2 receptor tyrosine kinase is required for the heart development and limb formationS Takeuchi, K Takeda, I Oishi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 2016
Multicenter randomized phase II study of cisplatin and fluorouracil plus docetaxel (DCF) compared with cisplatin and fluorouracil plus Adriamycin (ACF) as preoperative chemotherapy for resectable esophageal squamous cell carcinoma (OGSG1003)M Yamasaki, T Yasuda, M Yano, et al.
Annals of Internal Medicine|July 21, 1998
Relation of interferon therapy and hepatocellular carcinoma in patients with chronic hepatitis C. Osaka Hepatocellular Carcinoma Prevention Study GroupY Imai, S Kawata, S Tamura, et al.
Liver|August 26, 2000
Long-term responders without eradication of hepatitis C virus after interferon therapy: characterization of clinical profiles and incidence of hepatocellular carcinomaI Yabuuchi, Y Imai, S Kawata, et al.
International Journal of Cancer|April 10, 1997
CYP1A1, CYP2E1 and GSTM1 polymorphisms are not associated with susceptibility to squamous-cell carcinoma of the esophagusS Morita, M Yano, H Shiozaki, et al.
Journal of Viral Hepatitis|March 5, 2004
Interferon treatment improves survival in chronic hepatitis C patients showing biochemical as well as virological responses by preventing liver-related deathA Kasahara, H Tanaka, T Okanoue, et al.
Biochemistry|August 17, 2005
Allosteric activation of protein phosphatase 2C by D-chiro-inositol-galactosamine, a putative mediator mimetic of insulin actionD L Brautigan, M Brown, S Grindrod, et al.
Diabetes|May 26, 2001
Pancreatic biopsy as a procedure for detecting in situ autoimmune phenomena in type 1 diabetes: close correlation between serological markers and histological evidence of cellular autoimmunityA Imagawa, T Hanafusa, S Tamura, et al.
Diabetologia|May 20, 1999
Immunological abnormalities in islets at diagnosis paralleled further deterioration of glycaemic control in patients with recent-onset Type I (insulin-dependent) diabetes mellitusA Imagawa, T Hanafusa, N Itoh, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 1, 1996
[Hepatic resection with "wrapping therapy" for advanced hepatocellular carcinoma uncontrolled by arterial embolization]Y Sasaki, S Imaoka, H Nakano, et al.
Pageof 77